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Center Utrecht, Utrecht, and 4Department of Vascular Surgery, Radboud University, Nijmegen Medical
Centre, The NetherlandsAim. To evaluate the value of dynamic contrast enhanced magnetic resonance angiography (CE-MRA) for classification of
endoleaks after endovascular aneurysm repair (EVAR).
Materials and methods. Twenty-eight patients, between 2 days and 54 months after EVAR, were evaluated with CTA,
MRI and dynamic CE-MRA. The additional diagnostic value of the dynamic 3D CE-MRA was evaluated by determining
the ability of the dynamic series in pinpointing the site of inflow of an endoleak.
Results. An endoleak was detected in 23 patients. Seventeen of the 23 dynamic series were technically successful (no
disturbing artifacts limiting the diagnostic value). Using MRI our findings were: 2 type I, 6 type II, 1 type III, no type IV
endoleaks and in 14 cases classification could not be made. The classification results for MRI plus the dynamic CE-MRA
were: 2 type I, 12 type II, 1 type III, no type IV endoleaks and in eight cases classification could not be made. In six cases the
dynamic MRA allowed classification of the endoleak, which was not possible with the non-dynamic images alone (pZ0.091,
Fisher exact).
Conclusion. This pilot study shows that dynamic CE-MRA can have additional value in the classification of endoleaks.
Dynamic CE-MRA might obviate the need for diagnostic digital subtraction angiography and aid planning for intervention.Keywords: Abdominal aortic aneurysm; Endovascular; MRI; Diagnostic imaging; Endoleak.Background
Determining the effectiveness of exclusion after
endovascular aneurysm repair (EVAR) is essential for
the evaluation of treatment success and follow-up. The
absence or presence of endoleaks is therefore import-
ant in every assessment.1–4 If an endoleak is detected
on computed tomography angiography (CTA), a
decision must be made whether or not to intervene.
If the CTA assessment provides insufficient infor-
mation of the site of inflow or outflow of the endoleak,
most centers will use digital subtraction angiography
(DSA) to pinpoint the exact site of inflow in order to
plan an intervention to seal the endoleak.2,5–7 It can be
difficult to depict type II endoleaks and even small
type I endoleaks using this technique.8,9 An experi-
enced interventional radiologist can be more success-
ful using super selective DSA.8,10–13 DSA has thethe Young Vascular Surgeons Forum, ESVS, September
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contrast medium and radiation load to the patient, and
a small but significant morbidity and mortality.14–16
MRI and magnetic resonance angiography (MRA)
techniques, with their excellent soft tissue contrast,
lack of ionizing radiation and nephrotoxic contrast
agent form an interesting alternative to regular CTA
based follow-up. Moreover, recent developments in
MRI hardware and software, like the implementation
of SENSE (parallel imaging) and ultra fast gradient
systems have made fast dynamic scanning in 3D (also
called 4D scanning) possible. The time resolved 3D
MRA dataset is constructed out of sequential 3D
volumes and provides information about the contrast
dynamics without the need for invasive
catheterization.
It has previously been demonstrated that MRI and
MRA are more sensitive to endoleak detection than
CTA.17,18 We hypothesized that adding a time-
resolved MRA series to our standard non-dynamic
MRI-protocol for follow-up after EVAR would
improve endoleak classification. In order to investigate
whether this hypothesis holds true, a dynamic contrastEur J Vasc Endovasc Surg 31, 130–135 (2006)
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Dynamic MRA after EVAR 131enhanced (CE) MRA scan was added to our
standardized MRI scan protocol. The standard CTA
surveillance protocol, the standard MRI surveillance
protocol and CE dynamic MRA were compared.
Differences in pinpointing the exact sites of inflow
and the additional value of having information about
the filling phase for classifying endoleaks were
evaluated.Patients and MethodsPatients
In the period between March 2001 and March 2003,
28 patients randomly selected were included in the
study. This group consisted of 26 males and two
females with a mean age of 75 years (range 58–87),
treated by Excluder (nZ3, Gore, Flagstaff, AZ, USA)
or Ancure endografts (nZ25, EVT, Menlo Park, CA,
USA), who were imaged using CTA, MRI and
dynamic CE-MRA. Five patients were evaluated
twice and one patient three times resulting in 35
MRI and CTA data sets. Institutional review board
approval was obtained and all included patients
signed an informed consent form. Patients were
between 2 days and 65 month (mean 30 months)
after EVAR at the time of examination. The time
between the CT and the MR exam was minimized
and was not allowed to exceed 1 month.Design
The MRI scans and the CTA scans were evaluated for
the presence of endoleaks and for endoleak classifi-
cation. Endoleak was scored as present, not present or
uncertain. Classification of the endoleaks was per-
formed as proposed by White et al.: type I (leakage at
the attachment site), II (retrograde filling via branch
arteries), III (leakage due to a graft defect), IV (leakage
due to graft wall porosity) or unknown.7,19 The images
were evaluated by an experienced observer blinded to
the results of the other imaging modality. The data
were evaluated on a separate graphical workstation
(Easy Vision, Philips Medical Systems, Best, The
Netherlands).Clinical data acquisition techniques
Computed tomography angiography: CT scans were
performed on a spiral CT scanner (AV-EP, Philips
medical systems, Best, The Netherlands). The tablespeed used was 5 mm/s with a reconstruction index of
2 mm and a pitch of 0.25. One non-contrast-enhanced
scan and one with an intravenous infusion of 140 ml
Ultravist at 3 ml/s with a 30 s delay between the start
of the injection and the start of the scan were acquired
at 120 kV and 250 mA with a matrix size of 250. In
order to reduce the radiation dose for the patients,
delayed CT series (2 scans with 2 and 4 min interval
after the CTA) were only performed in case an
endoleak was suspected, i.e. in case of a growing or
stable non-luminal volume of the aneurysm sac based
upon previous assessments.20
Magnetic resonance imaging and angiography:
MRI scans were performed on a clinical 1.5-T scanner
(Gyroscan Intera NT, Philips Medical Systems, Best,
The Netherlands). A quadrature wrap-around synergy
body coil was used as a receive coil. The following
scans out of our MRI-protocol for follow-up after
EVAR were used for this study:
1. Pre-contrast T1-weighted spin echo: TR/TE/aZ
580 ms/14 ms/908, slice thickness 6.0 mm, 30
slices, FOV 270!385 mm2, acquisition matrix
179!256. Total acquisition time: 2.30 s.
2. Coronal dynamic 3D contrast enhanced (CE)-
MRA using SENSE factor 2 (approximately 6.5 s
per volume): TR/TE/aZ4.0 ms/1.3 ms/508, slice
thickness 4.0 mm interpolated to 2 mm slices, 28
slices, FOV 360!450 mm2, Matrix 154!256. Ten
dynamic volumes with breath hold technique for
as long as the patient could hold his/her breath.
Twenty milliliter of Gd-DTPA contrast agent
(Magnevist, Schering, Berlin, Germany) was
administered intravenously at 2.0 ml/s, followed
by a saline chaser bolus of 20 ml injected at
1.5 ml/s. The injection of the contrast agent was
started together with the acquisition of the
dynamic series.
3. Coronal 3D CE-MRA: TR/TE/aZ8.5 ms/
2.1 ms/458, slice thickness 3.0 mm interpolated
to 1.5 mm slices, 35 slices, FOV 360!450 mm2,
Matrix 154!512. Total acquisition time was 28 s
with the breath hold technique. Twenty millilitres
of contrast agent was injected intravenously at
2.0 ml/s, followed by a saline chaser bolus of
20 ml at 1.5 ml/s.
4. Post-contrast T1-weighted spin echo (as pre-
contrast).
In the complete MRI scan protocol, 40 ml of Gd-
DTPA was administered intravenously. The MRI
images were made anonymous and evaluated by an
experienced observer. A comparison of the pre-
contrast and post-contrast T1-weighted spin echoEur J Vasc Endovasc Surg Vol 31, 2 2006
Fig. 1. A comparison of a slice of a T1-weighted pre- and post-contrast scan at exactly the same location in the patient,
demonstrating an endoleak.
M. J. van der Laan et al.132scan was used for endoleak detection. The 3D CE-
MRA scan was used for endoleak classification. First
both T1-weighted spin echo scans and the 3D CE-MRA
were assessed. In a second evaluation the dynamic CE-
MRA was added to the data available to the observer.
Differences between the detection and classification of
endoleaks with and without the dynamic scan were
noted. During the second evaluation the observer was
blinded to the results of the first evaluation. Dynamic
scans were considered technically unsuccessful if
diagnostic evaluation was seriously compromised by
patient motion, fold-over artifacts or inadequate
planning, and the observer was asked to report
unsuccessful scans.Fig. 2. An example of a MIP of a 3D CE-MRA scan. The arrow
is pointing at a clearly visible type II endoleak filling the
aneurysm sac.Image analysis
All scans were loaded onto the graphical work-
station. Analysis of the CTA images involved: A
comparative stack view of the unenhanced CT and
the enhanced CTA, and multi planar reconstructions
(MPR) and central lumen line (CLL) reconstructions
of the contrast enhanced scan. Analysis of the MRI
and MRA images involved: A comparative stack
view of the unenhanced T1-weighted scan and the
T1-weighted scan after contrast enhancement, an
evaluation of maximum intensity projections (MIP)
of the CE-MRA, a MPR and CLL reconstructions of
the CE-MRA and T1-weighted scan after contrast
enhancement, a 3D evaluation of the (MIP) of the
dynamic series and an evaluation of the individual
slices of the dynamic series.Eur J Vasc Endovasc Surg Vol 31, 2 2006Statistical analysis
For statistical analysis of the difference in endoleak
classification a Fisher exact test was used. A p-value of
less than 0.05 was considered significant.Results
In the evaluation of the 35 CTA data sets 11 endoleaks
(31%) were identified in 11 patients. In five cases
classification of the detected endoleak was not
possible. Using MRI 23 (65%) endoleaks were detected
in 35 MRI examinations by comparison of T1-weighted
pre- and post-contrast scans. An example is shown
Fig. 3. An example of the MIP of a dynamic 3D CE-MRA scan (the same patient as in Fig. 2). Every image is the MIP of a 3D
volume out of the 4D dataset in which the volumes were acquired 6.2 s after each other. The contrast arrival, dispersion and
outflow are visualized. The arrow points at a small type II endoleak.
Dynamic MRA after EVAR 133in Figs. 1 and 2. All endoleaks identified with use of
CTA were identified on MRI evaluation. In 17 of the 23
cases with an endoleak, the dynamic MRA scan was
technically successful (69%). Four scans were unsuc-
cessful due to inadequate scan planning and two were
unsuccessful due to movement of the patient.
In six cases the addition of the dynamic CE-MRA
scan allowed classification of the endoleak, which was
not possible with use of the non-dynamic scans only
(Fig. 3). The overall classification results for our
standard protocol without the dynamic CE-MRA
were: 2 type I, 6 type II, 1 type III, no type IV endoleaks
and in 14 cases classification could not be made. The
classification results for our standard protocol plus the
dynamic CE-MRA were: 2 type I, 12 type II, 1 type II,
no type IV endoleaks and in eight cases classification
could not be made (Table 1; pZ0.091, Fisher exact). All
type I and type III endoleaks could be depicted with
use of the dynamic CE-MRA. Relatively smallTable 1. Here the results of our evaluation of endoleak detection and
Number of endoleaks detected Type I Type
Standard CTA protocol 2 3
Standard MRI protocol 2 6
Standard protocol plus dynamic CE-MRA 2 12
The standard CTA post-EVAR protocol and the standard MRI post-EVA
with the additional dynamic CE-MRA.endoleaks could not be depicted using the dynamic
series.Discussion
MRI evaluation after EVAR is more sensitive to
endoleak detection than CTA.18,21–23 The addition of
time-resolved or dynamic series to the standard
MRI/MRA protocol can aid in the determination of
the location of inflow of an endoleak. The dynamic
scan though, can only be used in combination with the
other scans due to the moderate resolution, which is a
result of the added temporal resolution. The non-
dynamic MRA and the post CE T1-weighted MRI must
direct the observer to the site of interest. A practical
problem is that the dynamic scan results in an
excessive amount of data, which makes it difficult to
interpret and requires a powerful graphicalclassification are summarized
II Type III Type IV Unknown type Total
1 0 5 11
1 0 14 23
1 0 8 23
R protocol without the dynamic CE-MRA is compared to the protocol
Eur J Vasc Endovasc Surg Vol 31, 2 2006
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With regard to the comparison of the MRI data to the
CTA data, it should be noted that, for reasons of dose
reduction, delayed CT series were not made in all
patients. Only patients who had aneurysm sac
enlargement at previous evaluations were subjected
to delayed CT series. This could theoretically have
resulted in an underestimation of the number of
endoleaks found in the CT scans.24 However, the
delayed series that were made, did not result in the
detection of additional endoleaks. In clinical practice
only selected patients should be subjected to delayed
CT series, as the cumulated exposure of the patient to
ionizing radiation would get unacceptably high.25 The
use of dynamic MRA techniques may obviate the need
for such delayed CT scans.
In our current dynamic CE-MRA scan, the acqui-
sition of each 3D volume takes approximately 6.2 s.
This fast image acquisition is achieved by making use
of parallel imaging, which means that the sensitivity
profiles of the receiver coils are used to combine
simultaneously received signals from multiple coil
elements into an image while scanning less ky-lines. A
disadvantage of this acquisition technique is that scan
planning is very important, since due to the parallel
imaging reconstruction, fold-over artifacts project in
the region of interest. In addition, the higher temporal
resolution results in a decreased signal-to-noise ratio
(SNR). However, in our experience this decreased SNR
did not have an impact on the diagnostic value of the
scans. Our main interest was imaging of contrast
dynamics and since we used 20 ml of Gd-DTPA in a
heavily T1-weighted scan, the intrinsic contrast to
noise ratio (CNR) between the vessels and the
background tissue was very high. Another problem
of the dynamic scan is the moderate spatial resolution
of the images. Each acquired volume is a low
resolution version of the non-dynamic coronal 3D
CE-MRA (scan 3 in our protocol). The lower resolution
is the price to pay for the increased temporal
resolution. This is reflected in the fact that small
endoleaks could not be depicted using this technique.
The spatial resolution of our dynamic scan probably
was too low for this purpose. In the future, when
receiver coils capable of applying higher SENSE
factors in abdominal imaging become available, both
spatial and temporal resolution might be improved.
Ghosting artifacts due to respiratory motion of the
ventral wall present a difficult problem. Especially, in
the dynamic series, since the 1-min duration of this
scan makes it impossible to totally acquire it within a
single breath hold. The average patient suffering from
vascular disease will not be able to perform a breath
hold for a period longer than 30 s. Artifacts can,Eur J Vasc Endovasc Surg Vol 31, 2 2006however, be minimized in coronal scans, by placing
the scan volume as far dorsally as possible. In some of
the patients artifacts cannot be prevented due to the
extent of the aneurysm to the abdominal wall.
Our main conclusion is that adding dynamic CE-
MRA to the MRI protocol provides the observer with
the dynamic information only otherwise available
from DSA. Future studies will have to determine the
exact value and place of dynamic CE-MRA in the
EVAR follow-up. A larger study comparing a dedi-
cated MRI protocol including dynamic MRA to a CTA-
based follow-up protocol in patients with MR
compatible stent grafts is currently being started at
our institution.References
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